Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
THE ECONOMIST, COVER STORY OF MAY 21 ISSUE:
WHEN THE DRUGS DON'T WORK: THE RISE OF ANTIBIOTIC RESISTANCE
Also, there is a report of a bacteria RESISTANT TO ALL KNOWN ANTIBIOTICS
And we're under a nickel...
There is a solution for their problems. And imagine the threat of an outbreak during the seasons of pilgrimage to Mecca (Hadj, etc.). Seems to me they are thinking of avoiding such a disaster given how much they're dependent on tourist spending these days. And don't forget the weak price of oil which always threatens the stability of subsidies for cooking oil, milk, bread, gas i.e. staples...and in that part of the world you definitely don't want an irritable populace grumbling about hunger.
The market value of the company at this moment is about 20M, I guess, based on 6 cent share price.
The question of how much it would take to buy the company is another question completely.
I suggest bidding should start at 5 dollars/share....
Do you think he was astute enough to be certain of EPA approval prior to signing on with MZEI?
My own opinion is that he's done a sufficient amount in this field to take cognizance of the role of government in biomedical startups. I doubt that he's taking vacation while the share price slowly fizzles downward through the summer. JMO, fire away!
You must know of other modalities that can eradicate viruses from the environment.
I don't.
I think that this is a historic advance in medical science.
Medizone International, Inc. Press Release
MERS Coronavirus Defeated by AsepticSure
San Francisco, California, August 4, 2014, Medizone International, Inc. (The Company) (MZEI:QB, MZEI:OB) announces excellent midpoint results from its new anti viral research initiative in collaboration with a world renowned virology institute.
"Medizone has now completed multiple decontamination runs with well characterized samples of Adenovirus and MERS Coronavirus," stated Dr Michael Shannon, Medizone's President. "We are pleased to announce that each run has shown 100% kill in a full-scale room setting. Since all of the virology work has been carried out by an internationally respected team of virologists, we have complete confidence that these findings are correct. By destroying both of these viruses, one a non-enveloped virus and the second an enveloped Coronavirus, our understanding of the biological limits for AsepticSure® has been expanded dramatically and of course so has the range of medical applications."
Shannon went on to say: "Although still preliminary, we have successfully achieved a 6 log kill with the Adenovirus and a 5.4 log kill with the Coronavirus. Efforts are continuing with the Coronavirus to grow it in high enough concentrations to elucidate AsepticSure's full decontamination capability with this deadly virus. Once this work has been completed, we plan to shift our focus to Norovirus, the plague of the seven seas."
Shannon continued about the importance of this work: "These new findings should have intriguing implications for the management of new deadly outbreaks world wide. Experts in this field have known for years that bacterial spores and non enveloped viruses are at the top of the biological resistance list for pathogens and we have data by the truck load confirming that AsepticSure can achieve 100% kill of these pathogens at very high concentrations. What is most exciting about these recent findings is that highly lethal viruses such as Ebola, should be extremely susceptible to AsepticSure disinfection, which may therefore see AsepticSure emerge as a vital component in global efforts to control these new deadly outbreaks."
This Press Release may contain certain forward looking statements that could involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.
Medizone International, Inc.
Investor Relations, John Pentony
T: 415-331-0202
E: j.pentony@medizoneint.com
Media Contact, Gary Hanauer
T: (510) 686-1238
E: GarHan@aol.com
Medizone International, Inc.
For more information, visit:
http://www.medizoneint.com
Email: operations@medizoneint.com
What about today's results on eradication of MRS vieus by AS??
From Frontline on PBS:
http://www.pbs.org/wgbh/pages/frontline/hunting-the-nightmare-bacteria/?elq=99ab93aeeaf24c0dad18d8fc68c6c521&elqCampaignId=992
It's about antibiotic resistance and the physicians who deal with its complications.
No mention of MZEI, of course....
According to what I've read the SC ruled that EPA power over greenhouse gases is pretty much intact.
Are you thinking of the Aereo case??
the
NSD, you've raised some significant questions. These questions have been asked publicly and privately for years and no answers have been forthcoming. It would be interesting to hear Mr. Esposito's approach to a business plan and in fact such a plan may be bubbling its way up to the surface....one of these days. Until then it's more waiting.
Today from the CDC:
BREAKING NEWS March 26, 2014
Healthcare-Associated Infections Still Major Issue, CDC Says
Medscape Medical News
Read Now ›
CDC Expert Commentary
Hospital-Associated Infections in the United States: CDC's Snapshot in Time
We are all waiting for the EPA news and if anyone knows when its coming they're managing to keep mum about it.
Patience has always been a prerequisite for being an MZEI investor perhaps now more than ever.
In any case there are still books to read, people to help and new places to visit so there's no need to put life on hold while waiting for the EPA to speak.
I think they'll actually have to go in two separate directions: miniaturization for the home and small office market and massive upsizing and re-engineering for the industrial applications especially food safety, waste detoxification, etc.
I think the near future will be quite interesting for this company.
And what about disinfecting animal waste from farms (chicken, hogs, cattle, sheep, etc.) and turning it into clean water and nitrogenous fertilizer. Water is preserved and there's no need to pollute public waterways (as happened in the Chesapeake Bay due to dumping form chicken farms). Environmentally sound, economically feasible, win-win all the way around.
I suspect that the spinoffs of this technology will create a lot of jobs and a couple of fortunes, too.
Isn't it obvious that the entire pace of the AsepticSure project is being dictated by SWMM in coordination with Canadian medical authorities? SWMM has already said that they plan on aggressive marketing of the AS technology through 2020? It's in their official announcement, this is not guessing.
MZEI has been taken on by an established company and it doesn't take an Einstein to figure out who is the controlling entity. It's the big, powerful, well established, we have something to lose end of the partnership. SWMM got to be a strong company by not screwing up in public, among other issues.
All of this moaning and groaning on the MZEI board is less important than a flea landing on a whale.
Our future is in the hands of some smart Canadian docs and a strong Canadian company, end of story. We should hear about the EPA and the Belleville experiences one of these days. Then SWMM runs with the ball.
http://www.nytimes.com/2013/08/27/science/a-quest-for-even-safer-drinking-water.html?ref=science&_r=0
Today's NY Times, see above.
This is the ultimate public health challenge and MZEI has the answer.. The article discusses antibiotic resistance and the presence of biofilms in studies of public drinking water (tap water, in other words). These terms are well known aspects of the HAI problem, too, or at least they were prior to MZEI.
Imagine having the contract to keep the country's water pure....
Ben K's points are solid. Furthermore, it wouldn't surprise me if MZEi and SMWW have as part of their working agreement clauses which prohibit "freelancing" of the type people have suggested for the Tampaa Bay Bucs lockeer room facilities. I don't think SMWW would allow MZEI, in other words, to give the North American premiere of the technology on their own. Couple this with the fact that the EPA blessing/approval has not yet been received and all signs point to Canada as the coming future showcase for AsepticSure.
And as Ben wisely points out, these pathogens are not dying off on their own. We keep putting antibiotics in animal feed and shot-gunning antibiotics in clinical medicine and the result is that there are increasing numbers of resistant bacteria with mounting virulence and pathogenicity.
I think that your final sentence explains why the marketing, training, communication, etc. will be in the hands of our "big brother" SMWW in Canada. And since SMWW is considered to be a very well run enterprise=and since SMWW has publicly stated that they expect aggressive growth in this area for the next ten years-it seems to me that MZEI leadership has done well to place AS with SMWW.
Who knows if future marketing arrangements, etc. will be done along this Canadian model i.e. via an already established company? Considering the very wide range of applications for our product I think we should be hopeful for the future.
I think people are somehow forgetting that we're seeing the formation of an early nucleus of activity around this product(AS). There may be debugging and beta testing issues, these all have to be faced by the first people to touch the machine. This is not a video game. It takes hands on effort and daily engineering talent to bring a new device to market. Along the way there will be insights which will improve later generations of the machine.
The second point to remember is that things will go as well as possible for us if there are only the very minimum number of glitches. The new kid on the block can't show up with ragged clothes and scuffed shoes. We really have to be excellent from day one. I say let the engineers and professionals behind this do their form of due diligence and produce as close to a perfect specification meeting device as possible.
Say it again: this is not a video game.
With 8 or 9 units you could conceivably train people for operation and troubleshooting.
I guess the answer to your question is:because they think they are about to introduce the very best solution to the HAI problem the world has ever seen.
This article dates from August 2012. The outbreak occurred a year ago.
The airplane idea is a necessity, IMO. People have gotten exposed to TB, etc. on flights from India or Pakistan to London.
And yes, your meat is not necessarily safe. USDA approval is meaningless, obviously, so beware of rare burgers, etc.
Food farms are now a major source of resistant organisms. You wonder if there was exposure to animals for any of those MRSA patients up in Canada....
http://opinionator.blogs.nytimes.com/2013/07/09/breeding-bacteria-on-factory-farms/?ref=gl
Discussion of link of many MRSA cases to livestock; excessive use of antibiotics linked to appearance of MULTIDRUG RESISTANT bacterial species.
Several of us have suggested to management that this would be an important application of the AsepticSure technology i.e. raise animals without antibiotics!
http://www.nytimes.com/reuters/2013/07/04/world/europe/04reuters-europe-hospitals-infections.html?hp
From today's NYT. 3 million HAI's per year in Europe. If each infection adds a cost of 10K then you are looking at an extra 30 Billion/year of cost. Capture that business and calculate the share price...
any idea of a European effort by MZEI??
WIV, thanks for your analysis. One question; what significance do you attach to Wood Wyant's stated intention to aggressively market AS through 2020, per their press release? And do you think it's significant that WW appears to have performed their own scientific due diligence on AS (by report).?
Your Eli Manning pic tells me that your heart is in the right place. Keep up the good posting!
Not to worry, tomorrow's dips and gyrations irrelevant as long as company progresses toward its long term goals.
There is a statement from the company regarding patent and EPA discussions and further information
on upcoming trade shows and the progression of the Belleville trials.
The statement is the chairman's summer update.
Medizone International, Inc. [http://r20.rs6.net/tn.jsp?e=001wV530hDlTyKuiBl3C6VjfzbaEjgmFbS2O7TYA4h2EIzrZGsuTpVbUweicby1v4qVo6c0vgoYaTspUjYQFYdw06RkxZRcdEN6Zr_uR0Y_XQiLBO85FvQyiA==]
The results of the meetings are certainly of interest but MZEI is only one of the parties. Government agencies are the other side of the table and as I'm sure you realize from diplomatic or business announcements, all press releases are agreed upon by BOTH parties. In general government agencies try to avoid intrusion or scrutiny while doing their work. There will be news when the government is ready to make public statements and not before.
Just think of it as an engagement announcement or a wedding invitation: two parties required.
If the patent was thought to be a long shot why would EM have put this much time into maintaining the company? It's more logical and reasonable to think that EM was advised by our attorneys that the MZEI patent(s) would be granted in the U.S.? As a super ancient long I seem to recall someone stating that TWO SETS of patent attorneys gave thumbs-up INDEPENDENTLY. We were assured that the patent attorneys were the best in their fields.
I think that many of us are also nonplussed as to why we're running into so much trouble in the US while Canada and Singapore have granted the patent.
I think that the MZEI BOD should make a public clarification of the patent issues and their significance for the company's future.
Another need for AS-food inspection declining!
http://www.nytimes.com/2013/05/08/us/foreign-food-inspections-decline-as-illnesses-rise.html?src=rechp&_r=0
MZEI MENTIONED IN MARKET WATCH ARTICLE!
http://www.marketwatch.com/story/bedbugs-rack-up-hospital-bills-2013-04-22
Nice to see our unique technology starting to receive attention!
Dr. Zoutman quoted, too.
Probably nothing since ricin is a poison. AsepticSure is said to act by destroying bacterial cell walls and since ricin is not a living organism there would be no effect. Ozonated ricin should be just as deadly as plain ricin.
Wood Wyant has publicly stated that they expect aggressive growth in this market through 2020, refer to original announcement of distribution partnership.
Is it possible that they know what they're talking about? Is is possible that they understand the growth potential of AsepticSure even better than iHub posters?
Yes, it is possible.
3 Million dollars divided by 300 Million shares = .01 dollar = one cent/share
One of the key phrases in Mr. Patrick Couture's statement refers to AsepticSure as having the potential to be a "paradigm changing prodcut".
This is definitely how the technology should be marketed. AsepticSure was independently evaluated by Wood Wyant and evidently passed with flying colors.
Aggressive marketing through 2020, see announcement.
Congrats to the young longs, the middle aged longs and most of all to the ancient prehistoric and pre-Biblical longs.
Isn't it odd that we've received patents for Singapore and Canada but have supposedly been turned down by the US, per # 28050?
Is this an anomaly? Canadian medicine and science are considered top rate and Canadian patent examiners are certainly on a par with US counterparts.
Something is off here...and I hope that the company responds publicly ASAP.
That's a very clever idea..why shouldn't we have our own governmental relations person (=lobbyist) in touch with the relevant D.C. officials?